TRex Bio
About:
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Website: http://www.trex.bio/
Top Investors: Eli Lilly, Alexandria Venture Investments, Polaris Partners, SV Health Investors, Eli Lilly & Company Foundation
Description:
TRexBio is a biotechnology company that leverages cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop therapeutics for cancer and inflammatory diseases. Its 'deep biology' discovery engine maps human tissue Treg behavior to disease processes, identifying and characterizing novel targets for therapeutic intervention. The platform supports the development of a portfolio of therapies that modulate the immune system to restore tissue immune homeostasis.
$169M
$1M to $10M
South San Francisco, California, United States
2018-01-01
Ravi Rao
11-50
2024-11-13
Private
© 2025 bioDAO.ai